Archive for the ‘Treatment’ Category

Study: SOT Potential Treatment For Viruses & Lyme Disease

https://pubmed.ncbi.nlm.nih.gov/36412742/

Supportive Oligonucleotide Therapy (SOT) as a Potential Treatment for Viral Infections and Lyme Disease: Preliminary Results

Free PMC article

Abstract

Antisense therapy is widely used as an alternative therapeutic option for various diseases. RNA interference might be effective in infections, through the degradation of messenger RNA and, therefore, translation process. Hence, proteins essential for microorganisms and viruses’ proliferation and metabolism are inhibited, leading to their elimination. The present study aimed to evaluate the use of oligonucleotide in patients infected by Epstein-Barr (EBV) or Herpes Simplex Viruses 1/2 or with Lyme Disease caused by Borrelia burgdorferi. Blood samples were collected from 115 patients and the different species were characterized using molecular biology techniques. Then, SOT molecules (Supportive Oligonucleotide Therapy), which are specific small interfering RNA (siRNA), were designed, produced, and evaluated, for each specific strain. Oligonucleotides were administered intravenously to patients and then a quantitative Polymerase Chain Reaction was used to evaluate the effectiveness of SOT. This study revealed that for Lyme Disease, one or two SOT administrations can lead to a statistically significant decrease in DNA copies, while for viruses, two or three administrations are required to achieve a statistically significant reduction in the genetic material. These preliminary results indicate that antisense SOT therapy can be considered a potential treatment for viral as well as Lyme diseases.

For more:

The challenge with Lyme is correctly identifying the patient’s infections as they are typically coinfected with many. Further, it’s all based on using PCR to detect the DNA of various bacteria which is known to find Lyme only 30% of the time.  Further, many of the organisms with Lyme/MSIDS aren’t found in the blood so trying to detect it there is futile (another reason this is so hard to test, diagnose, and treat.)

Using genetic code for a treatment for this is like trying to catch a greased pig.  Lyme in particular changes its outer surface protein which means what goes into you isn’t what comes out of you as the organism mutates to survive.  Yet another reason it’s difficult treating this and why there has never and will never be a Lyme vaccine worth its weight in salt.  You can’t pin something down that changes.

Personally, all this work on treatments using genetics scares the bajeebers out of me.  Hopefully the past three years have caused all of us to pause and consider the implications of using genes and their ability to alter genetic code.  Also, what works in a petri dish often doesn’t work in reality.

Of course, at the end of the day, we are all big boys and girls and have to make our own decisions.  What works for one often doesn’t work for another and if you do your reading, are convinced of its merits, and want to try this, then by all means do it.  If you have success, or if you don’t, please let me know.  Often the best way we move forward is by educating one another on various treatments and health changes.

Shape-Shifting Antibiotics?

https://www.pnas.org/doi/10.1073/pnas.2208737120

Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria

Edited by Kyriacos Nicolaou, Rice University, Houston, TX; received May 20, 2022; accepted February 24, 2023
April 3, 2023
120 (15) e2208737120
Abstract
The alarming rise in superbugs that are resistant to drugs of last resort, including vancomycin-resistant enterococci and staphylococci, has become a significant global health hazard. Here, we report the click chemistry synthesis of an unprecedented class of shapeshifting vancomycin dimers (SVDs) that display potent activity against bacteria that are resistant to the parent drug, including the ESKAPE pathogens, vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), as well as vancomycin-resistant S. aureus (VRSA). The shapeshifting modality of the dimers is powered by a triazole-linked bullvalene core, exploiting the dynamic covalent rearrangements of the fluxional carbon cage and creating ligands with the capacity to inhibit bacterial cell wall biosynthesis. The new shapeshifting antibiotics are not disadvantaged by the common mechanism of vancomycin resistance resulting from the alteration of the C-terminal dipeptide with the corresponding d-Ala-d-Lac depsipeptide. Further, evidence suggests that the shapeshifting ligands destabilize the complex formed between the flippase MurJ and lipid II, implying the potential for a new mode of action for polyvalent glycopeptides. The SVDs show little propensity for acquired resistance by enterococci, suggesting that this new class of shapeshifting antibiotic will display durable antimicrobial activity not prone to rapidly acquired clinical resistance.

Tick Disease Endemic in 10 States; What That Means

https://weather.com/health/video/tick-disease-now-endemic-in-10-states-heres-what-that-means  News Video Here (Approx. 1 Min)

Tick Disease Endemic In 10 States; What That Means

The Weather Channel

April 1, 2023

Some tick diseases are at record highs and one in particular is Babesiosis which is now endemic in 10 states.  Pets can be infected with it as well.

For more:

In Fantasy World: FDA Commissioner Blames ‘Misinformation’ For Lowering U.S. Life Expectancy

http://  Approx. 9 Min

Dr. Suneel Dhand

April 18, 2023

KEY POINTS
  • In a 30 minute interview with CNBC, Dr. Robert Califf said better regulation is needed to combat health misinformation that’s rampant online.
  • He also said the agency, though it has no direct role in drug pricing, will use its bully pulpit more.
  • New obesity drugs bring “great hope,” Califf said, but need more data.
This is a warning shot over the bow, folks.

Buckle up for more censorship!

Pro Big Pharma Califf and corrupt public health agencies want to limit our access to health information – particularly information that conflicts with the government narrative.  Remember, these agencies completely failed with COVID by mandating measures that did nothing to lower mortality, continue to fail Lyme/MSIDS patients and are the worst purveyors of misinformation that has killed  untold thousands.  The sole emphasis upon experimental, fast-tracked, gene therapy injections as well as government sanctioned, ineffective and dangerous treatments continues to cause unmeasurable harm, when there are numerous effective, safe, treatments that have been censored and shut down by those desiring to stop all competitive health information by labeling it ‘misinformation.’  It’s an age-old bullying tactic they continue to utilize.

While Dhand rightly attacks food corporations for junk food, as well as point out crucial topics like diabetes, obesity, etc. – let’s never forget the mortality issue is occurring directly after the roll-out of the COVID shots

But, of course it’s all #ABV.

For more:

From the book:

“Millennials (ages 25-44) saw an acceleration of excess mortality into the second half of 2021 to new all-time highs, a stunning 84% above baseline.

Dowd, Ed. “Cause Unknown”: The Epidemic of Sudden Deaths in 2021 & 2022 (Children’s Health Defense) (p. 151). Skyhorse. Kindle Edition. “

It includes an analysis of the new-in-2021 post-mortem “diagnosis” of sudden adult death syndrome, analysis of events in VAERS following my, and Dr. Jessica Rose’s days-after shot distribution analysis, as well as the meteoric rise in VAERS reports in myocarditis and pericarditis.

Those wanting to normalize this call it the more official sounding title of SADS “Sudden Adult Death Syndrome,” which of course doesn’t include the thousands of healthy young people including perfectly healthy athletes suddenly collapsing on the field and dying, or the “off the charts” miscarriages, fetal abnormalities, and fetal deaths.

Cast Reports: Orbital Myositis Due to Lyme Disease

https://danielcameronmd.com/case-reports-orbital-myositis-due-to-lyme-disease/

CASE REPORTS: ORBITAL MYOSITIS DUE TO LYME DISEASE

myositis-lyme-disease

In their article “Two Cases of Orbital Myositis as a Rare Feature of Lyme Borreliosis,” Sauer et al. describe two female patients with focal orbital myositis due to Lyme disease. [1]

Orbital myositis is typically caused by systemic disease, such as Grave’s disease, or haematological disorders like lymphomas, the authors explain. In these cases, myositis is often bilateral. It has been reported, as well, as a rare manifestation of Lyme disease.

In these two cases, myositis was confirmed by MRI findings.

Patient #1: 68-year-old female

“The 68-year-old patient had acute and recurrent episodes (lasting from 2 to 4 weeks, 2 to 4 times each year) of right orbital swelling and pain,” the authors wrote.

Each episode resolved spontaneously or with steroids and nonsteroidal anti-inflammatory drugs.

Lyme disease was suspected since the patient was living in a rural area of France, highly endemic for Lyme disease, and she recalled having numerous tick bites and had a history of an erythema migrans rash and arthralgia.

Testing for Lyme disease was positive and the woman began treatment with doxycycline. Within 3 weeks, her symptoms had resolved.

“We reported the cases of two patients who presented with orbital myositis caused by Borrelia infection.”

Patient #2: 13-year-old female

The 13-year-old adolescent complained about unilateral orbital swelling complicated with exophthalmia and horizontal diplopia.

“MRI showed a hyperintense signal of right inferior and medial rectus muscles,” the authors wrote.

The woman was living in an area endemic for Lyme disease and had a recent tick bite followed by an Erythema migrans rash.

Lyme disease testing was positive and she was treated successfully with 4 weeks of doxycycline.

The authors reported, “a resolution of ocular symptoms and a decrease of the MRI signal intensity were observed within 1 month.”

The authors conclude:

  • “Orbital myositis is an unusual manifestation of Lyme disease, although it is likely that the condition is underdiagnosed.”
  • Unexplained muscle swelling occurring in a patient who has had a rash or a recent history of a tick bite in an endemic area for Lyme disease should prompt consideration of this diagnosis.”
References:
  1. Sauer A, Speeg-Schatz C, Hansmann Y. Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis. 2011;2011:372470. doi: 10.1155/2011/372470. Epub 2011 Jul 28. PMID: 22567470; PMCID: PMC3336248.

________________

**Comment**

Where to even begin……

  1. Rarely reported is a far different matter than rarely occurs.  Everything about Lyme/MSIDS is downplayed. This most probably happens a lot.
  2. I hesitate to ponder what would have occurred if they hadn’t each tested positive, which is akin to winning the lottery with tests that miss 70% and in this case, 86% of cases.  Current 2-tiered CDC testing also completely omits testing for any coinfections which are quite common.
  3. The second patient had a tick-bite followed by the bullseye rash.  This proves she is infected with Lyme.  No testing required since the rash is diagnostic for Lyme – yet ‘the powers that be’ continue to take the deadly “wait and see” approach and continue to utilize faulty, inadequate testing for diagnosis and treatment.  It seems nothing ever changes.
  4. They continue to treat infected patients with the inadequate and limited mono-therapy of doxycycline, despite research and reality proving this doesn’t work.
  5. Like all other studies, these patients need lengthy follow-up.  IF that occurred, I guarantee that research would prove the current therapy simply doesn’t work.

For more on eye issues with Lyme/MSIDS: